First patient dosed in Gesynta Pharma's endometriosis trial of vipoglanstat The Manila Times
First patient dosed in Gesynta Pharma's endometriosis trial of vipoglanstat beQuoted
First patient dosed in Gesynta Pharma's endometriosis trial of vipoglanstat Cision
Transforming endometriosis diagnoses Scitech
PhD grad from the U of A is transforming women's health KVOA
To evaluate whether ultrasound-based #Enzian classification predicts pain profiles and response to hormonal therapy in patients with endometriosis. Endometriosis is a chronic inflammatory disease affecting 10% of reproductive-age women, often …
A murine model of endometriosis was employed to evaluate the pharmacological efficacy of therapeutic compounds. Endometriosis was modeled by autotransplantation of uterine horn fragments onto the intestinal mesentery in three …
Infertility affects one in six individuals worldwide despite the advancement of assisted reproductive technologies. Successful embryo implantation is the first step of pregnancy, which relies on the establishment of a …
"Benign gynecologic conditions" is an umbrella term widely used to describe prevalent conditions such as endometriosis, adenomyosis, uterine fibroids, and genitourinary syndrome of menopause in clinical guidelines, research, reviews, and …
Simple test could transform time to endometriosis diagnosis Medical Xpress